Within the field of neurodegeneration, we specialize in the treatment and research of Dementia and Parkinson’s Disease. Our dedicated team focuses on these specific conditions, utilizing the latest scientific advancements and methodologies. Our commitment to excellence and innovation continues to drive our research forward, offering hope and new possibilities to those affected by these challenging conditions.
We’re committed to advancing the understanding and treatment of Dementia through pioneering clinical trials and cutting-edge research. Specializing in this complex neurodegenerative condition, we are dedicated to developing innovative therapies aimed at improving patient outcomes and quality of life. Join us in our mission to push forward the frontiers of Dementia research, striving to offer new hope and effective treatments to individuals affected by this challenging condition.
Read moreAt Julius Clinical we lead neurodegenerative disease treatments through advanced clinical trials, collaborating with experts and using cutting-edge methods to develop innovative therapies for better patient outcomes amidst nerve cell deterioration and related neurological issues.
Read moreWe’re committed to advancing the understanding and treatment of Dementia through pioneering clinical trials and cutting-edge research. Specializing in this complex neurodegenerative condition, we are dedicated to developing innovative therapies aimed at improving patient outcomes and quality of life. Join us in our mission to push forward the frontiers of Dementia research, striving to offer new hope and effective treatments to individuals affected by this challenging condition.
Read moreAt Julius Clinical we lead neurodegenerative disease treatments through advanced clinical trials, collaborating with experts and using cutting-edge methods to develop innovative therapies for better patient outcomes amidst nerve cell deterioration and related neurological issues.
Read moreOn 30 May, we hosted the webinar "Real-World Data in ALS", in which we explored the innovative integration of Real World Data (RWD) in clinical trials for Amyotrophic Lateral Sclerosis (ALS). As a critical step forward in the pursuit of effective ...
On May 9, we presented the webinar: Selecting and successfully integrating cognitive testing into clinical trialsDuring this webinar, hosted by Dr. Lieza Exalto, speaker Dr. John Harrison discussed:Cognitive domains – which ones sho...
In collaboration with our partner Brain Research Center, we presented the webinar: Measuring and tracking everyday functioning in AD clinical trials with the Amsterdam IADL QuestionnaireSpeakers:Dr. Sietske Sikkes | Associate Professor a...
Explore our Neurodegeneration trial capabilities, case studies, and other resources.
"*" indicates required fields
"*" indicates required fields
